Abstract

Objective(s): In this study, the effects of different doses of curcumin application on Ehrlich ascites tumor (EAT) created in the mice of BALB/c type were investigated.

Materials and Methods: Curcumin extracts can have hindering effect on tumor volume, vascular density, EAT cells around the tissues, and can support apoptosis. EAT cells (1x106) received from stock animals were injected intraperitoneally (IP) and subcutaneously (SC) to the animals. Then, curcumin was administered IP. Doses of 25 mg/kg IP and 50 mg/kg were administered over 10 days to the animals in the treatment groups in which ascites tumor was induced. The same doses were administered over 15 days in the treatment groups in which solid tumor was induced.

Results: Histopathological examination in ascites tumor groups revealed that number of EAT cells at surrounding tissues was smaller in the group received 50 mg/kg curcumin when compared to tumor control group (P<0.05). The lowest increase in tumor volume was observed in the group received 25 mg/kg curcumin when compared to tumor control group (P<0.05).

Conclusion: It was demonstrated once again in our study that curcumin had an anti-tumoral effect on both the development of ascites tumor created through EAT cells and the development of solid tumor.

Details

Title
Investigating the anti-tumoral effect of curcumin on the mice in which Ehrlich ascites and solid tumor is created
Author
Yilmaz, Seher  VIAFID ORCID Logo  ; Ülger, Harun; Ertekin, Tolga; Yay, Arzu; Nisari, Mehtap; Alpa, Şerife  VIAFID ORCID Logo  ; Acer, Niyazi
Pages
418-425
Section
Original Article
Publication year
2019
Publication date
Apr 2019
Publisher
Mashhad University of Medical Sciences
ISSN
20083866
e-ISSN
20083874
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2381682574
Copyright
© 2019. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.